DesignPlex Biomedical, founded in 2015, was created to address a critical need in medical device development for early-stage implanted blood pumps, artificial hearts, and related peripheral equipment. Over the years, the company has broadened its expertise to support advanced technologies including optogenetics for neuromodulation, medication dosing systems, reliability test fixtures, wound care innovations, pacemaker management tools, heart simulators, and specialized solutions for fat grafting. During the COVID-19 pandemic, DesignPlex also contributed to public health efforts by developing face shields, face masks, ventilator components, and antimicrobial coating technologies. Today, DesignPlex Biomedical is proudly ISO 13485:2016 certified for the design and manufacturing of active implantable medical devices (AIMDs), reinforcing its commitment to quality, safety, and regulatory excellence in the medical device industry.